Healthcare ❯ Pharmaceuticals

Weight Loss

GLP-1 Drugs GLP-1 Medications Drugs Medications Obesity Treatments Drug Development GLP-1 Products GLP-1 Program Wegovy Semaglutide Treatment Comparison GLP-1 Hormones GLP-1 Treatments Body Weight Percentage GLP-1 Injections Health-Tech Partnerships

Novo Nordisk Lifts 2026 Outlook as Wegovy Pill Powers Big Q1 Beat

Early use patterns point to market expansion with many patients starting treatment with pills.

GSK Gains After Cramer Endorsement as Company Pushes Into Weight-Loss Drugs

Eli Lilly Tightens GLP-1 Grip, Guides Up to $83 Billion for 2026

Eli Lilly’s Q4 Beat and Bullish Outlook Give Way to Stock Drop on Low-Cost GLP-1 Pills

Novo Nordisk Presses India Expansion and Higher-Dose Push as Analyst Views Diverge